LMCLX
Price
$10.39
Change
+$0.09 (+0.87%)
Updated
Aug 21 closing price
Net Assets
190.09M
PAAJX
Price
$16.78
Change
+$0.09 (+0.54%)
Updated
Aug 21 closing price
Net Assets
2.1B
Interact to see
Advertisement

LMCLX vs PAAJX

LMCLX vs PAAJX Comparison Chart in %
View a ticker or compare two or three
VS
LMCLX vs. PAAJX commentary
Aug 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMCLX is a Buy and PAAJX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PAAJX has more cash in the bank: 2.1B vs. LMCLX (190M). LMCLX pays higher dividends than PAAJX: LMCLX (3.92) vs PAAJX (1.68). LMCLX was incepted earlier than PAAJX: LMCLX (12 years) vs PAAJX (7 years). LMCLX (1.05) is less costly to investors than PAAJX (0.70). LMCLX is a more actively managed with annual turnover of: 44.00 vs. PAAJX (32.00). LMCLX (1000000) and PAAJX (1000000) have matching initial minimum investment requirements. LMCLX annual gain was more profitable for investors over the last year : 19.77 vs. PAAJX (15.66). LMCLX return over 5 years is better than : 42.15 vs. PAAJX (14.43).
LMCLXPAAJXLMCLX / PAAJX
Total Expense Ratio1.050.70150%
Annual Report Gross Expense Ratio1.050.70150%
Fund Existence12 years7 years-
Gain YTD17.02212.997131%
Front LoadN/AN/A-
Min. Initial Investment10000001000000100%
Min. Initial Investment IRAN/AN/A-
Net Assets190M2.1B9%
Annual Yield % from dividends3.921.68233%
Returns for 1 year19.7715.66126%
Returns for 3 years85.1041.73204%
Returns for 5 years42.1514.43292%
Returns for 10 years133.49N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BEKE17.750.76
+4.47%
KE Holdings
YEXT6.350.11
+1.76%
Yext
CLDX40.380.44
+1.10%
Celldex Therapeutics
ANTA3.84-0.03
-0.78%
Antalpha Platform Holding Company
MSGY2.22-0.28
-11.20%
Masonglory Limited